Pharmaceutical CMC and New Drug Development Expert: Small Molecules, Proteins and Biologics

Technical Consultant #2052


  • Accomplished chemist and regulatory professional with over 25 years' experience in Pharmaceutical and Biotechnology industries.
  • CMC (Chemistry, Manufacturing and Controls), analytical chemistry and drug development of small molecules, proteins and biologics (cells, viruses, plasmids).
  • CMC programs for oral, inhaled, topical and parenteral dosage forms.
  • Technical and program-level supervision of formulation, analytical and manufacturing in support of product-manufacturing processes for small molecule, protein, and plasmid therapeutics.
  • Strategic, technical, and regulatory direction for pharmaceutical development.
  • INDs/NDAs for the U.S. FDA, developing regulatory strategy, and liaison with FDA.
  • Regulatory and development.


Undisclosed Company, Founder and CEO, 2009 - Present

  • Consulting, pharmaceutical development for small molecules and biologics.
  • Advancing IND, (Investigational New Drug), projects from preclinical to POC, (Proof of Concept).
  • Development of formulations, dosage form, analytical methods, stability programs.
  • Outsource management of CMC, (Chemistry Manufacturing and Controls) and bioanalytical from audit to clinical studies.
  • Frequent interaction with CBER, (Center for Drug Evaluation and Research,) and CDER, (Center for Drug Evaluation and Research) of U.S., FDA.
  • Writing and review of regulatory documents to support INDs and NDAs.
  • Initiated operations: CMC consulting.
  • Planning and executing CMC regulatory submissions.
  • Managed intellectual property portfolio and patent prosecution.
  • Consulted and authored STTR (Small Business Technology Transfer), SBIR, (Small Business Innovation Research) and ATP, (Advanced Technology Programs) proposals.

Summit Drug Development Services, LLC, Rockville, MD, 2007 - 2009

Vice President, Pharmaceutical Development Services, 2008 - 2009
Consultant, CMC and Analytical Chemistry, 2007 - 2008

  • Managed development projects for multiple clients.

Scynexis, Inc., Research Triangle Park, NC, 2002 - 2007

Director of Scientific Affairs and Drug Development

  • Advanced HCV program from preclinical and pre - IND to Ph. 2 in 18 months.
  • Responsible for HIV and HCV discovery and development.
  • Responsible for preclinical research and regulatory operations.
  • Team leader for proprietary discovery program: antiviral and ophthalmology.
  • Inventor of several new therapeutics: antiviral and dry eye compounds.

Director of Analytical Sciences

  • Responsibility for QC analytical chemistry and bioanalytical functions.
  • Team of 14 scientists: GLP and cGMP compliant operations.
  • Project Team leader for drug-discovery project: antiviral agent.

Phytera, Inc., Worcester, MS, Director, Chemistry, 2000 - 2001

  • Medicinal chemistry and analytical chemistry in drug development programs.
  • CMC Regulatory writing.

Paradigm Genetics, Inc. , Research Triangle Park, NC, 1998 - 2000

Group Leader, Biochemistry

  • Small-molecule biomarker development.
  • Established initial metabolite screening, analytical methods/systems, and automation platform.
  • Biochemical-assay development team.

OSI Pharmaceuticals, Inc., Durham, NC, Uniondale, NY, Director of Chemistry, 1994 - 1998

  • Research-operations director for drug discovery center (screening and chemistry).
  • Responsible for research activities in biology and chemistry.
  • Member of Technology Development Committees.
  • Team leader in drug discovery projects (cancer, virology, hematopoiesis): Discovered antiviral agents, EPO inducers, and anti-sickle-cell agents.
  • Directed SAR programs.

Sterling Winthrop Pharmaceuticals, Research Division, Collegeville, PA, 1989 - 1994

Principal Research Investigator, 1993 - 1997
Senior Research Investigator, 1991 - 1993
Research Investigator, 1989 - 1991

  • For the Department of Biochemistry and Biomolecular Screening, managed biochemistry and biocatalysis research team.
  • Developed high-throughput assays for inflammation programs.
  • Developed functional and binding assays for new targets.
  • Developed novel HTS assay for metalloproteases.
  • Managed enzymology and biochemistry group.

Los Alamos National Laboratory, Los Alamos, NM, 1987 - 1989

Fellow, Isotope and Structural Chemistry Group

  • Enzyme kinetics and mechanisms of alcohol dehydrogenases.
  • Biocatalysis using PPQ-based dehydrogenase.
  • Synthesis and biosynthesis of isotopically labeled coenzymes and enzymes.

Merck and Company, Inc., Rahway, NJ, 1981 - 1987

Senior Biochemist, 1986 - 1987
Research Biochemist, 1984 - 1986
Biochemist, 1981 - 1984

  • Development research on biocatalytic processes, and production of anti-bacterials,statins, CCK receptor antagonists.
  • Developed analytical methods for over 100 compounds.

Honors & Publications

Academic and Professional Affiliations

  • Editorial Board, Journal of Antibiotics
  • North Carolina Regulatory Affairs Forum
  • Center for Entrepreneurial Development, NC
  • American Association of Pharmaceutical Scientists (AAPS)
  • Drug Information Association (DIA)


  • Recipient of Merck Ph.D. Fellowship and Research-Achievement Award

Publications and Patents

  • Author and Co-Author of Numerous: Meeting abstracts, scholarly journals, book chapters and symposia with the following topics:
  • National and international patents.


  • Ph.D. Chemistry, Ohio State University, Columbus, OH
  • M.S. Biochemistry, Purdue University, West Lafayette, IN
  • B.S. Biology, Summa Cum Laude, Alma College, Alma, MI
Save Resume #2052
to Contact Form?

You must first click "Yes" to save this resume

Submit Request

You have no Saved Resumes

Add resumes within our various Ares of Expertise by clicking "Add Resume(s)" below.

Add Resume(s)